{"id":432871,"title":"Notice: Prescription Drug List (PDL): Naloxone - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T09:04:25.993000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-naloxone.html?wbdisable=true","snippet":"Notice: Prescription Drug List (PDL): Naloxone March 22, 2016 Our file number: 16-103373-445 The purpose of this Notice of Amendment is to notify that as a result of consultation Health Canada has revised the listing for naloxone on the Prescription Drug List (PDL). Health Canada…","rawSnapshotUrl":"/api/snapshots/raw/432871","browseUrl":"https://replay.healtharchive.ca/job-6/20260102090425/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-naloxone.html?wbdisable=true#ha_snapshot=432871","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}